Expression of osteoprotegerin in placenta and its association with preeclampsia.
<h4>Background</h4>Osteoprotegerin (OPG), a key regulatory factor in bone metabolism, was documented also a potential pro-angiogenic factor, which acts an important role in protecting vascular endothelial cells. Since preeclampsia has gradually been employed to be vascular diseases, we s...
Main Authors: | Pei Shen, Yunhui Gong, Tao Wang, Yueyue Chen, Jin Jia, Shanshan Ni, Bin Zhou, Yapin Song, Lin Zhang, Rong Zhou |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22952959/?tool=EBI |
Similar Items
-
Inconformity of CXCL3 plasma level and placenta expression in preeclampsia and its effect on trophoblast viability and invasion.
by: Shunping Gui, et al.
Published: (2014-01-01) -
Differential expression of GPR30 in preeclampsia placenta tissue and normal placenta tissue and its clinical significance
by: Ben-Zhou Feng
Published: (2016-04-01) -
Metastin expression in the placenta tissue of preeclampsia and its effect on the trophoblast cell proliferation and apoptosis
by: Jia-Yan Wang
Published: (2018-04-01) -
Placenta-Derived Osteoprotegerin Is Required for Glucose Homeostasis in Gestational Diabetes Mellitus
by: Binbin Huang, et al.
Published: (2020-09-01) -
LncRNAs expression in preeclampsia placenta reveals the potential role of LncRNAs contributing to preeclampsia pathogenesis.
by: Xiaoju He, et al.
Published: (2013-01-01)